Arcadia Biosciences, Inc.

Equities

RKDA

US0390143032

Agricultural Chemicals

Market Closed - Nasdaq 04:30:00 2024-04-24 pm EDT 5-day change 1st Jan Change
2.06 USD +1.47% Intraday chart for Arcadia Biosciences, Inc. +1.48% -34.19%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Arcadia Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Arcadia Biosciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Earnings Flash (RKDA) ARCADIA BIOSCIENCES Reports Q4 Revenue $1.2M, vs. Street Est of $1.8M MT
Arcadia Biosciences, Inc. Expands Goodwheat? Mac & Cheese with Nationwide Availability CI
Arcadia Biosciences, Inc. Announces the Resignation of Laura Pitlik as Chief Marketing Officer CI
Arcadia Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Arcadia Biosciences, Inc., Q3 2023 Earnings Call, Nov 09, 2023
Earnings Flash (RKDA) ARCADIA BIOSCIENCES Reports Q3 Revenue $1.6M, vs. Street Est of $1.55M MT
Origin Materials Names Matt Plavan as Finance Chief MT
Arcadia Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Transcript : Arcadia Biosciences, Inc., Q2 2023 Earnings Call, Aug 10, 2023
Earnings Flash (RKDA) ARCADIA BIOSCIENCES Posts Q2 Revenue $1.4M, vs. Street Est of $1.59M MT
Arcadia Biosciences Exploring Strategic Options Including Sale, Merger; Shares Climb MT
Arcadia Biosciences Announces Strategic Review CI
Arcadia Biosciences, Inc. Launches Goodwheat into the Breakfast Category with New Better-For-You Pancake & Waffle Mixes and Single-Serve Quikcakes CI
HC Wainwright Adjusts Price Target on Arcadia Biosciences to $15 From $18, Keeps Buy Rating MT
Arcadia Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Transcript : Arcadia Biosciences, Inc., Q1 2023 Earnings Call, May 11, 2023
Arcadia Biosciences Files Shelf on Behalf of Selling Stockholders MT
Lake Street Adjusts Arcadia Biosciences Price Target to $20 From $80, Maintains Buy Rating MT
Arcadia Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Transcript : Arcadia Biosciences, Inc., Q4 2022 Earnings Call, Mar 30, 2023
Arcadia Biosciences, Inc. Auditor Raises 'Going Concern' Doubt CI
Top Premarket Decliners MT
Arcadia Biosciences Enters Agreements for $6 Million Private Placement of Common Stock, Preferred Investment Options MT
Chart Arcadia Biosciences, Inc.
More charts
Arcadia Biosciences, Inc. is a producer and marketer of plant-based food and beverage products. The Company is engaged in developing crop improvements, primarily in wheat, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. The Company is using non-genetically modified (non-GMO) advanced breeding techniques to develop products. Its product portfolio includes GoodWheat Pasta, GoodWheat Pancakes and Waffle Mixes, GoodWheat Mac and Cheese, Zola Coconut Water, and GoodWheat Wheat Traits. Its GoodWheat pasta has five varieties of penne, spaghetti, fettuccine, elbows, and rotini. Its GoodWheat pancake and waffle mixes are sold in resealable, multi-serve pouches, and mixes are available in three varieties, including buttermilk, chocolate chip and apple cinnamon. It operates under Saavy Naturals, Soul Spring, and ProVault brands. ProVault, is a THC-free CBD sports performance formula made with natural ingredients.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.06 USD
Average target price
11 USD
Spread / Average Target
+433.98%
Consensus